Capstone Investment Advisors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$299K Buy
+3,087
New +$317K ﹤0.01% 1365
2025
Q4
Sell
-6,035
Closed -$767K 1728
2025
Q3
$767K Buy
6,035
+2,611
+76% +$311K ﹤0.01% 1137
2025
Q2
$420K Buy
+3,424
New +$391K ﹤0.01% 1221
2024
Q2
Sell
-18,185
Closed -$1.5M 2182
2024
Q1
$1.5M Buy
+18,185
New +$1.33M 0.01% 918
2023
Q4
Sell
-10,687
Closed -$718K 2180
2023
Q3
$718K Buy
+10,687
New +$735K ﹤0.01% 1134
2016
Q3
Sell
-9,176
Closed -$283K 782
2016
Q2
$283K Buy
+9,176
New +$287K 0.01% 568

Other funds holding EHC

Capstone Investment Advisors's EHC Position: Q1 2026 in Review

Capstone Investment Advisors opened a new position in Encompass Health (EHC) in Q1 2026: 3,087 shares worth $299K. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings. This is a return to the name: Capstone Investment Advisors previously reported a position in EHC as recently as Q3 2025.

Capstone Investment Advisors first reported a position in EHC in Q2 2016 and has held it in 6 quarters since. The position peaked at $1.5M in Q1 2024. 579 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Capstone Investment Advisors held 3,087 shares of Encompass Health worth $299K as of Q1 2026.
  • Encompass Health was a new Capstone Investment Advisors position in Q1 2026.
  • Encompass Health made up ﹤0.01% of Capstone Investment Advisors's portfolio in Q1 2026, its #1365 holding.
  • Capstone Investment Advisors first reported a position in Encompass Health in Q2 2016 and has held it in 6 quarters since.
  • Capstone Investment Advisors's Encompass Health position peaked at $1.5M in Q1 2024.
  • 579 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Capstone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.